文献速递慢性静脉疾病静脉血栓栓塞

髂腔静脉支架置入术后一年结果

One-Year Results of Iliocaval Stenting.
PubMed 文献 · Ann Vasc Surg · 2019-03-01

本研究评估急性和慢性静脉疾病患者因髂腔静脉阻塞或受压接受介入治疗的结果。81.5%患肢在12个月内某阶段症状缓解,但12个月末仅59.3%保持无症状,无截肢和30天内死亡。

要点

  • 髂腔和髂股静脉成形加支架置入在急慢性阻塞中安全可行,通畅率良好。
  • 慢性病例12个月支架通畅率89.9%,高于急性病例的76.9%。
  • 12个月末仅59.3%患肢保持无症状,症状改善可能随时间回落。

核心结论

  • 髂腔和髂股静脉成形加支架置入在急性和慢性阻塞病例中均可安全实施,通畅率良好且慢性静脉功能不全症状有合理改善。

主要发现

  • 急性病例支架通畅率在3、6、12个月分别为84.6%、76.9%、76.9%。
  • 慢性病例(血栓性和非血栓性合并)支架通畅率在3、6、12个月分别为93.1%、91%、89.9%。
  • 81.5%患肢在12个月内某阶段症状缓解(多数在前3个月内),但12个月末仅59.3%保持无症状。
  • 无截肢,干预后30天内无死亡。

临床怎么用

  • 对CVI C3-C6或急性深静脉血栓患者,确认髂腔或髂股段阻塞后可行静脉成形加支架置入,急性血栓病例先予药物机械和/或导管定向溶栓再对残余阻塞置入支架。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the study was to assess results of interventions for iliocaval obstruction or compression in patient with acute and chronic venous disease. METHODS: Patients with chronic venous insufficiency (CVI) C3-C6 (Clinical, Etiology, Anatomy, Pathology - classification of venous insufficiency) and acute deep venous thrombosis were assessed by ultrasound scan, computed tomography, venography, and/or intravascular ultrasound, and if an obstruction in their iliocaval or iliofemoral segments were confirmed, they underwent venoplasty and stenting. Acute deep venous thrombosis cases were treated with pharmacomechanical and/or catheter-directed thrombolysis and residual obstruction was then stented. RESULTS: One hundred eighteen consecutive limbs were treated between October 2011 and December 2017. Thirty-two limbs had an active ulcer (27%), 27 limbs had healed ulcer or advanced skin changes (23%), 39 limbs had swelling with or without other symptoms of CVI (33%), 15 limbs had acute symptomatic deep venous thrombosis (13%), and the residual 5 iliac vein cases were causing pelvic congestion syndrome (4%). Patency rates of the stents in acute cases were 84.6%, 76.9%, 76.9%, and in chronic cases (combined thrombotic and nonthrombotic) 93.1%, 91%, and 89.9% in 3, 6, and 12 months, respectively. A relief of symptoms was achieved in 81.5 % of limbs at some stage during the first 12 months (most of them within the first 3 months), although at the end of this period only 59.3% remained free of symptoms. There was no limb loss and no mortality within 30 days from the intervention. CONCLUSIONS: Iliocaval and iliofemoral venoplasty and stenting in both acute and chronic obstruction cases can be performed safely with good patency rates and reasonable improvement of symptoms of CVI.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tosenovsky P. One-Year Results of Iliocaval Stenting. Ann Vasc Surg. 2019. PMID: 30826434. doi:10.1016/j.avsg.2018.12.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。